This story has been updated from a previous version.

NEW YORK, June 12 – Affymetrix stock plunged  $14.94, or 36 percent, to close at $26.01 on Tuesday, following an announcement late on Monday that the company was slashing its second-quarter revenue expectations due to a drop in demand for the company’s gene chips and spot arrayers.

The company said its revenues for the quarter would total between $44 million and $50 million rather than $56 million to $58 million as previously expected.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.